240 related articles for article (PubMed ID: 30282832)
1. Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction.
Grundy L; Harrington AM; Castro J; Garcia-Caraballo S; Deiteren A; Maddern J; Rychkov GY; Ge P; Peters S; Feil R; Miller P; Ghetti A; Hannig G; Kurtz CB; Silos-Santiago I; Brierley SM
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282832
[TBL] [Abstract][Full Text] [Related]
2. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Guanylate Cyclase-C modulation of corticolimbic activation and corticotropin-releasing factor signaling in a rat model of stress-induced colonic hypersensitivity.
Ligon CO; Hannig G; Greenwood-Van Meerveld B
Neurogastroenterol Motil; 2021 Mar; 33(3):e14076. PubMed ID: 33373484
[TBL] [Abstract][Full Text] [Related]
4. Linaclotide inhibits colonic and urinary bladder hypersensitivity in adult female rats following unpredictable neonatal stress.
Ligon C; Mohammadi E; Ge P; Hannig G; Higgins C; Greenwood-Van Meerveld B
Neurogastroenterol Motil; 2018 Oct; 30(10):e13375. PubMed ID: 29797376
[TBL] [Abstract][Full Text] [Related]
5. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
[TBL] [Abstract][Full Text] [Related]
6. Serotonin exerts a direct modulatory role on bladder afferent firing in mice.
Konthapakdee N; Grundy L; O'Donnell T; Garcia-Caraballo S; Brierley SM; Grundy D; Daly DM
J Physiol; 2019 Nov; 597(21):5247-5264. PubMed ID: 31520534
[TBL] [Abstract][Full Text] [Related]
7. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
Eutamene H; Bradesi S; Larauche M; Theodorou V; Beaufrand C; Ohning G; Fioramonti J; Cohen M; Bryant AP; Kurtz C; Currie MG; Mayer EA; Bueno L
Neurogastroenterol Motil; 2010 Mar; 22(3):312-e84. PubMed ID: 19706070
[TBL] [Abstract][Full Text] [Related]
8. Pelvic organ cross-sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis.
Yoshikawa S; Kawamorita N; Oguchi T; Funahashi Y; Tyagi P; Chancellor MB; Yoshimura N
Neuroscience; 2015 Jan; 284():422-429. PubMed ID: 25445197
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological and clinical profile of linaclotide (Linzess
Keto Y; Kosako M
Nihon Yakurigaku Zasshi; 2019; 153(6):289-298. PubMed ID: 31178535
[TBL] [Abstract][Full Text] [Related]
10. Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase-C Activation in Reversing Bladder-Colon Cross-Sensitization.
Mohammadi EN; Ligon CO; Silos-Santiago A; Ge P; Kurtz C; Higgins C; Hannig G; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2018 Aug; 366(2):274-281. PubMed ID: 29784661
[TBL] [Abstract][Full Text] [Related]
11. Linaclotide treatment reduces endometriosis-associated vaginal hyperalgesia and mechanical allodynia through viscerovisceral cross-talk.
Ge P; Ren J; Harrington AM; Grundy L; Castro J; Brierley SM; Hannig G
Pain; 2019 Nov; 160(11):2566-2579. PubMed ID: 31335750
[TBL] [Abstract][Full Text] [Related]
12. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
Fukudo S; Nakajima A; Fujiyama Y; Kosako M; Nakagawa A; Akiho H; Nakashima Y; Johnston JM; Miwa H
Neurogastroenterol Motil; 2018 May; 30(5):e13275. PubMed ID: 29278278
[TBL] [Abstract][Full Text] [Related]
13. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity
Boulete IM; Thadi A; Beaufrand C; Patwa V; Joshi A; Foss JA; Eddy EP; Eutamene H; Palejwala VA; Theodorou V; Shailubhai K
World J Gastroenterol; 2018 May; 24(17):1888-1900. PubMed ID: 29740204
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
Silos-Santiago I; Hannig G; Eutamene H; Ustinova EE; Bernier SG; Ge P; Graul C; Jacobson S; Jin H; Liong E; Kessler MM; Reza T; Rivers S; Shea C; Tchernychev B; Bryant AP; Kurtz CB; Bueno L; Pezzone MA; Currie MG
Pain; 2013 Sep; 154(9):1820-1830. PubMed ID: 23748116
[TBL] [Abstract][Full Text] [Related]
15. Activation of colo-rectal high-threshold afferent nerves by Interleukin-2 is tetrodotoxin-sensitive and upregulated in a mouse model of chronic visceral hypersensitivity.
Campaniello MA; Harrington AM; Martin CM; Ashley Blackshaw L; Brierley SM; Hughes PA
Neurogastroenterol Motil; 2016 Jan; 28(1):54-63. PubMed ID: 26468044
[TBL] [Abstract][Full Text] [Related]
16. Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity.
Castro J; Harrington AM; Lieu T; Garcia-Caraballo S; Maddern J; Schober G; O'Donnell T; Grundy L; Lumsden AL; Miller P; Ghetti A; Steinhoff MS; Poole DP; Dong X; Chang L; Bunnett NW; Brierley SM
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31536477
[TBL] [Abstract][Full Text] [Related]
17. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
[TBL] [Abstract][Full Text] [Related]
18. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain.
Brierley SM; Grundy L; Castro J; Harrington AM; Hannig G; Camilleri M
Trends Pharmacol Sci; 2022 Feb; 43(2):110-122. PubMed ID: 34865885
[TBL] [Abstract][Full Text] [Related]
19. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.
Rao SS; Quigley EM; Shiff SJ; Lavins BJ; Kurtz CB; MacDougall JE; Currie MG; Johnston JM
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889
[TBL] [Abstract][Full Text] [Related]
20. NaV1.1 inhibition can reduce visceral hypersensitivity.
Salvatierra J; Castro J; Erickson A; Li Q; Braz J; Gilchrist J; Grundy L; Rychkov GY; Deiteren A; Rais R; King GF; Slusher BS; Basbaum A; Pasricha PJ; Brierley SM; Bosmans F
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
